Amazon jumps into direct-to-consumer telehealth, launching a rival to Ro and Hims
“Amazon seems to be wandering in the experimental floundering stage,” said Erik Gordon, a business and law professor at the University of Michigan.
“Amazon seems to be wandering in the experimental floundering stage,” said Erik Gordon, a business and law professor at the University of Michigan.
Download STAT’s e-book to explore the challenges and steps to improve care for an aging population.
On May 8, join us for a conversation with practicing neurologists about overcoming current hurdles involved in diagnosing, treating, and monitoring patients in a new…
Amgen said it’s “very encouraged” by interim Phase 2 data for its obesity drug, quickly sparking investor interest. Here are the burning questions surrounding Amgen’s…
A virtual-second model can have long-term benefits across the health care system, from improving patients’ experiences to growing the telehealth market.
A bipartisan Senate bill takes a new approach to persistent drug shortages: have Medicare pay bonuses to hospitals and physicians for contracting that ensures a…
Amgen said that it will no longer develop an early-stage obesity pill, and will instead focus on an injectable candidate that’s seen as a potential…
Whether or not the USPSTF says “B” or “C,” the goal is for women in their 40s to have informative conversations with their health care…
A STAT Investigation: Brain biopsies on “vulnerable” patients at Mount Sinai set off alarm bells at FDA, documents show.
Check out the inaugural edition of Adam’s Biotech Scorecard, a new newsletter from @statnews.
The drug-pricing watchdogs over at the Institute for Clinical and Economic Review tend to be supportive of gene therapy pricing, even when the price is…